Kido Y, Tamai I, Uchino H, Suzuki F, Sai Y, Tsuji A
Faculty of Pharmaceutical Sciences, Kanazawa University, Japan.
J Pharm Pharmacol. 2001 Apr;53(4):497-503. doi: 10.1211/0022357011775794.
We present here the evidence of molecular and functional expression of LAT1 and LAT2, subunits of the large neutral amino acid transporter system L, in cultured brain capillary endothelial cells of the rat. By means of the RT-PCR method, transcripts of LAT1, LAT2 and heavy chain of 4F2 antigen (4F2hc) were detected in rat primary cultured brain capillary endothelial cells (BCECs) and immortalized subline, RBEC1. The uptake properties of RBEC1, such as [3H]leucine and L-[3H]DOPA uptake, were similar to those of primary cultured BCECs. So, RBEC1 may retain almost native properties of the large neutral amino acid uptake activities. [3H]Leucine uptake by RBEC1 showed two saturable components and the Km values of the high- and low-affinity components were 8.92+/-3.18 and 119+/-45 microM, respectively. The Km value of the high-affinity component agreed well with that of LAT1 and the amino acid transport selectivity of RBEC1 was similar to that of LAT1. Therefore, it is suggested that LAT1 is important at the blood-brain barrier of rats. Additionally, the Km value of the low-affinity component was similar to that of LAT2. These observations indicate that LAT1 and LAT2 are involved as transporters for large neutral amino acids at the blood-brain barrier. Additionally, we concluded that RBEC1 is useful as an in-vitro model for evaluation of the pharmacological relevance of system L at the blood-brain barrier.
我们在此展示大鼠脑毛细血管内皮细胞培养物中大分子中性氨基酸转运系统L的亚基LAT1和LAT2的分子及功能表达证据。通过逆转录聚合酶链反应(RT-PCR)方法,在大鼠原代培养脑毛细血管内皮细胞(BCECs)和永生化亚系RBEC1中检测到LAT1、LAT2和4F2抗原重链(4F2hc)的转录本。RBEC1的摄取特性,如[3H]亮氨酸和L-[3H]多巴摄取,与原代培养的BCECs相似。因此,RBEC1可能保留了大分子中性氨基酸摄取活性的几乎天然特性。RBEC1对[3H]亮氨酸的摄取显示出两个可饱和成分,高亲和力和低亲和力成分的Km值分别为8.92±3.18和119±45 microM。高亲和力成分的Km值与LAT1的Km值吻合良好,且RBEC1的氨基酸转运选择性与LAT1相似。因此,提示LAT1在大鼠血脑屏障中起重要作用。此外,低亲和力成分的Km值与LAT2的Km值相似。这些观察结果表明,LAT1和LAT2作为大分子中性氨基酸的转运体参与血脑屏障的功能。此外,我们得出结论,RBEC1作为一种体外模型,可用于评估系统L在血脑屏障中的药理学相关性。
Brain Res. 2000-10-6
Invest Ophthalmol Vis Sci. 2005-7
Neuroreport. 2000-11-9
Behav Brain Res. 2021-9-24
Neurobiol Pain. 2020-6-30
Front Neurosci. 2020-1-22